Skip to main content
letter
. 2017 Mar 10;7(3):e540. doi: 10.1038/bcj.2017.18

Figure 1.

Figure 1

PFS. Abbreviations: ELd, elotuzumab plus lenalidomide and dexamethasone; Ld, lenalidomide and dexamethasone; PFS, progression-free survival.